CTOR
Price
$1.70
Change
-$0.09 (-5.03%)
Updated
Oct 17 closing price
Capitalization
141.97M
HIMS
Price
$49.78
Change
-$9.37 (-15.84%)
Updated
Oct 17 closing price
Capitalization
11.25B
15 days until earnings call
Interact to see
Advertisement

CTOR vs HIMS

Header iconCTOR vs HIMS Comparison
Open Charts CTOR vs HIMSBanner chart's image
Citius Oncology
Price$1.70
Change-$0.09 (-5.03%)
Volume$182.96K
Capitalization141.97M
Hims & Hers Health
Price$49.78
Change-$9.37 (-15.84%)
Volume$74.58M
Capitalization11.25B
CTOR vs HIMS Comparison Chart in %
View a ticker or compare two or three
VS
CTOR vs. HIMS commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTOR is a Hold and HIMS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (CTOR: $1.70 vs. HIMS: $49.78)
Brand notoriety: CTOR and HIMS are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: CTOR: 80% vs. HIMS: 262%
Market capitalization -- CTOR: $141.97M vs. HIMS: $11.25B
CTOR [@Pharmaceuticals: Generic] is valued at $141.97M. HIMS’s [@Pharmaceuticals: Generic] market capitalization is $11.25B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.85B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTOR’s FA Score shows that 0 FA rating(s) are green whileHIMS’s FA Score has 1 green FA rating(s).

  • CTOR’s FA Score: 0 green, 5 red.
  • HIMS’s FA Score: 1 green, 4 red.
According to our system of comparison, HIMS is a better buy in the long-term than CTOR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTOR’s TA Score shows that 2 TA indicator(s) are bullish while HIMS’s TA Score has 5 bullish TA indicator(s).

  • CTOR’s TA Score: 2 bullish, 6 bearish.
  • HIMS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, HIMS is a better buy in the short-term than CTOR.

Price Growth

CTOR (@Pharmaceuticals: Generic) experienced а -0.58% price change this week, while HIMS (@Pharmaceuticals: Generic) price change was -7.73% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.79%. For the same industry, the average monthly price growth was +4.23%, and the average quarterly price growth was +51.45%.

Reported Earning Dates

HIMS is expected to report earnings on Nov 03, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.79% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HIMS($11.3B) has a higher market cap than CTOR($142M). HIMS YTD gains are higher at: 105.873 vs. CTOR (47.826). HIMS has higher annual earnings (EBITDA): 155M vs. CTOR (-25.48M). HIMS has more cash in the bank: 1.15B vs. CTOR (112). CTOR has less debt than HIMS: CTOR (3.8M) vs HIMS (1.04B). HIMS has higher revenues than CTOR: HIMS (2.01B) vs CTOR (0).
CTORHIMSCTOR / HIMS
Capitalization142M11.3B1%
EBITDA-25.48M155M-16%
Gain YTD47.826105.87345%
P/E RatioN/A63.01-
Revenue02.01B-
Total Cash1121.15B0%
Total Debt3.8M1.04B0%
FUNDAMENTALS RATINGS
HIMS: Fundamental Ratings
HIMS
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
48
SMR RATING
1..100
22
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CTORHIMS
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
47%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
15%
Bearish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 10 days ago
87%
Declines
ODDS (%)
Bearish Trend 9 days ago
82%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
27%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CTOR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HIMS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CCMCF0.370.04
+11.36%
Core Critical Metals Corp.
MNILY17.55N/A
N/A
Minor International Public Co., Ltd.
PVBK10.60N/A
N/A
Pacific Valley Bancorp
VIRDY74.00N/A
N/A
Viridien
NCBDY15.62-0.01
-0.07%
Bandai Namco Holdings, Inc.

CTOR and

Correlation & Price change

A.I.dvisor tells us that CTOR and HIMS have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTOR and HIMS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTOR
1D Price
Change %
CTOR100%
-5.03%
HIMS - CTOR
20%
Poorly correlated
-15.84%
TKNO - CTOR
14%
Poorly correlated
-2.47%
UTHR - CTOR
9%
Poorly correlated
+0.15%
ALVO - CTOR
7%
Poorly correlated
-0.34%
RDHL - CTOR
7%
Poorly correlated
-4.46%
More

HIMS and

Correlation & Price change

A.I.dvisor tells us that HIMS and COTY have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HIMS and COTY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HIMS
1D Price
Change %
HIMS100%
-15.84%
COTY - HIMS
31%
Poorly correlated
+4.58%
EWCZ - HIMS
30%
Poorly correlated
-1.15%
HROW - HIMS
29%
Poorly correlated
+5.51%
ALKS - HIMS
27%
Poorly correlated
-1.75%
ETON - HIMS
25%
Poorly correlated
-0.87%
More